Cargando…
Current Knowledge about the New Drug Firibastat in Arterial Hypertension
Hypertension significantly increases the risk of cardiovascular disease. Currently, effective standard pharmacological treatment is available in the form of diuretics, ACE inhibitors, angiotensin II receptor blockers and calcium channel blockers. These all help to decrease blood pressure in hyperten...
Autores principales: | Hansen, Emma, Grimm, Daniela, Wehland, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836050/ https://www.ncbi.nlm.nih.gov/pubmed/35163378 http://dx.doi.org/10.3390/ijms23031459 |
Ejemplares similares
-
Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials
por: Alomar, Sara Abdulrahman, et al.
Publicado: (2021) -
Latest Knowledge on the Role of Vitamin D in Hypertension
por: Jensen, Niklas S., et al.
Publicado: (2023) -
Current Knowledge about the Impact of Microgravity on Gene Regulation
por: Corydon, Thomas J., et al.
Publicado: (2023) -
The Effect of Continuous Positive Airway Pressure Therapy on Obstructive Sleep Apnea-Related Hypertension
por: Baran, Ronni, et al.
Publicado: (2021) -
The Impact of Vitamin D in the Treatment of Essential Hypertension
por: Legarth, Christian, et al.
Publicado: (2018)